Picture Not Available

Robert W. Mason, PhD

Contact Dr. Mason


,


Most Recent Peer-reviewed Publications

  1. Growth impairment in mucopolysaccharidoses
  2. Neurophysiology of hearing in patients with mucopolysaccharidosis type IV
  3. Natural history of Morquio A patient with tracheal obstruction from birth to death
  4. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II
  5. Development of bone targeting drugs
  6. Epidemiology of mucopolysaccharidoses
  7. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII
  8. Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
  9. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia
  10. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses
  11. Gene therapy for Mucopolysaccharidoses
  12. Glycosaminoglycans detection methods: Applications of mass spectrometry
  13. Mucopolysaccharidosis IVA and glycosaminoglycans
  14. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry
  15. Current therapies for Morquio A syndrome and their clinical outcomes
  16. Activity of daily living for Morquio A syndrome
  17. Cathepsin inhibition prevents autophagic protein turnover and downregulates insulin growth factor-1 receptor-mediated signaling in neuroblastoma
  18. Stability of furosemide and chlorothiazide stored in syringes
  19. Non-invasive pulmonary function test on Morquio patients
  20. Chondroitin and keratan sulfate